Israeli-based digital health technology company GrayMatters Health, which develops self-neuromodulation therapies for mental disorders, received FDA 510(k) clearance for its PTSD-focused neuromodulation therapy dubbed Prism.
The company uses a proprietary model to create a unique patient amygdala-derived biomarker, using synchronized data from several sessions of electroencephalograms (EEGs)...
Digital Medicare advisor Chapter landed $42 million in a Series B funding round led by Addition, with participation from Narya Capital, Susa Ventures, Maverick Ventures, XYZ Venture Capital, Core Innovation Capital and Health2047 Capital Partners.
The company is able to help employers work with their employees on switching their plans to Medicare. Patients can use the platform to navigate the...
